FMP
Enveric Biosciences, Inc.
ENVB
NASDAQ
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
0.934 USD
0.0366 (3.92%)
About
ceo
Dr. Joseph Edward Tucker Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.enveric.com
exchange
NASDAQ
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
CIK
0000890821
ISIN
US29405E2081
CUSIP
29405E208
Address
4851 Tamiami Trail North
Phone
239 302 1707
Country
US
Employee
7
IPO Date
May 4, 2015
Summary
CIK
0000890821
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
29405E208
ISIN
US29405E2081
Country
US
Price
0.93
Beta
0.58
Volume Avg.
4.45M
Market Cap
6.81M
Shares
-
52-Week
0.649-6.98
DCF
1.06
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.12
P/B
-
Website
https://www.enveric.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ENVB News
It looks like there's no news available.
